The Department of Consumer Protection announced today that new preliminary data shows combined sales for adult-use cannabis and medical marijuana totaled more than $18.4 million for the period from Feb. 1, 2023, to Feb. 28, 2023, the first complete calendar month since adult-use sales began.
The adult-use market recorded $7.02 million in sales during the month of February, while the medical marijuana market recorded $11.4 million in sales for the same period. February is the first complete calendar month for which data is available. Adult-use sales began on Jan. 10, 2023.
The Department also made available new data related to adult-use cannabis and medical marijuana sales. The new data shows the total number of products sold in each market, as well as the average price per product in each market.
In the month of February, Medical Marijuana Patients purchased 316,644 products, and adult-use consumers purchased 168,565. The DCP Drug Control Division has approved more than 600 new brand names for products that may be sold in both the medical marijuana market and the adult-use market since the adult-use market opened.
The average product price for Medical Marijuana patients was $36.11 in February, while the average price of adult-use products was $41.82. This data was collected through the state’s Seed-to-Sale Tracking System. DCP does not make revenue projections, set sales expectations, or regulate prices.
The data does not include taxes collected at the point of sale on adult-use transactions, and is subject to further review by the department. Medical marijuana patients do not pay taxes on the purchase of their medicine.
Sales data for the medical marijuana market is not available prior to Jan. 10, 2023, as seed-to-sale tracking was not previously required for medical marijuana sales. Adult-use and medical marijuana sales are now recorded in BioTrack, the inventory tracking system used to monitor the movement of cannabis products in the state’s medical and adult-use cannabis markets.
Transaction limits of 1/4 ounce of raw flower or the equivalent remain in effect for all adult-use purchases. Medical marijuana patients may purchase up to 5 ounces per month and are not subject to individual transaction limits.
